Noven Pharmaceuticals

This is the limited version of the Noven Pharmaceuticals company profile: Join LinkedIn or Sign In to see more information.

Current Company Logo

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of prescription pharmaceutical products. Noven’s business and operations are focused in three principal areas – transdermal drug delivery, the Novogyne joint venture, and Noven Therapeutics, Noven’s specialty pharmaceutical unit. Noven is committed to developing and offering products and technologies that meaningfully benefit patients, its customers and its industry partners. For more information, visit www.noven.com.

Your Connections to Noven Pharmaceuticals

To see how you’re connected: Join Now or Sign In

Popular Profiles at Noven Pharmaceuticals

New Hires and Recent Promotions at Noven Pharmaceuticals

  • Patricia Soper, Exec. Assistant to President & CEO

    was Legal Specialist - 4 months ago

  • Johan Sierra, Benefits Administrator

    was HR Assistant - 3 months ago

  • Gabriella Toth, Associate Research Scientist, Flux Lab

    was Assistant Research Scientist, Flux Lab - 5 months ago

  • Vincent Lau Chan, Associate Research Engineer

    was Assistant Research Engineer - 6 months ago

  • Tyrone Ortiz, QA Technical Supervisor

    was Manufacturing Technical Supervisor II - 6 months ago

To see more new hires & promotions: Join Now or Sign In

Last edited by Vice President - Corporate Affairs at Noven Pharmaceuticals

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about Noven Pharmaceuticals. This page is not endorsed by or affiliated with Noven Pharmaceuticals. For questions regarding LinkedIn Company Profiles, contact us.

Noven Pharmaceuticals (NOVN) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions